6533b7d4fe1ef96bd12628ec

RESEARCH PRODUCT

Novel Biocompatible Cationic Copolymers Based on Polyaspartylhydrazide Being Potent as Gene Vector on Tumor Cells

Gennara CavallaroNicole TietzeArun K. KothaArun K. KothaErnst WagnerGaetano GiammonaFabio Salvatore PalumboManfred Ogris

subject

Erythrocyte AggregationBiocompatibilityCell SurvivalPolymersPharmaceutical ScienceBiocompatible MaterialsBiologyTransfectionDNA condensationMiceNeuroblastomachemistry.chemical_compoundIn vivoCationsCell Line TumorZeta potentialAnimalsPolyethyleneiminePharmacology (medical)Particle SizeCytotoxicityPharmacologyPolyethylenimineCytotoxicity liver toxicity nonviral gene delivery transfectionDose-Response Relationship DrugLiver DiseasesBody WeightOrganic ChemistryGenetic transferDNATransfectionMolecular WeightLiverchemistryBiochemistryNucleic Acid ConformationMolecular MedicineFemaleChemical and Drug Induced Liver InjuryPeptidesBiotechnology

description

Introduction. The reaction between !,"-poly(aspartylhydrazide) (PAHy), a water soluble synthetic polymer and 3-(carboxypropyl)trimethyl-ammonium chloride (CPTACl) produced copolymers bearing permanent positive charges (PAHy–CPTA) with molecular weight of 10 kDa and PAHy–CPTA copolymers differing in positive charge amount (18–58%) were chosen for biological investigations. Materials and methods. Biophysical properties of DNA/PAHy–CPTA polyplexes were evaluated in terms of DNA condensation, zeta potential and size distribution. Cytotoxicity studies on Neuro2A murine neuroblastoma cells evidenced absence of toxicity of these copolymers up to 300 2g/ml unlike linear polyethylenimine (LPEI) that was highly toxic already at 20 2g/ml. Results and Discussion. PAHy–CPTA copolymers did not induce any erythrocyte aggregation up to 1 mg/ml. Cellular interaction studies of PAHy–CPTA polyplexes evidenced a faster binding of these polyplexes with cells compared to DNA/LPEI polyplexes. The in vitro transfection ability of PAHy– CPTA polyplexes was strongly affected by experimental conditions reaching about 10% of the transfection efficiency of optimized LPEI polyplexes. Conclusions. Finally, in vivo application studies confirmed the biocompatibility of PAHy–CPTA copolymers. With LPEI, clear signs of microvesicular fatty liver were observed and with LPEI polyplexes significant weight loss. In strong contrast, PAHy–CPTA did not induce histopathological changes or weight loss.

https://doi.org/10.1007/s11095-007-9403-4